PHASE 1 INVESTIGATION INTO THE SAFETY, TOLERABILITY,...

Alzheimer's & Dementia 2017 / 07 Vol. 13; Iss. 7

PHASE 1 INVESTIGATION INTO THE SAFETY, TOLERABILITY, PHARMACOKINETICS (PK) AND PHARMACODYNAMICS (PD) OF E2027, A SELECTIVE PHOSPHODIESTERASE-9 (PDE9) INHIBITOR

Lai, Robert Y.K., Gordon, Robert, Chang, Min-Kun, Boyd, Peter, Savant-Landry, Ishani, Aluri, Jagadeesh, Ino, Mitsuhiro, Horie, Kanta, Kotani, Sadaharu, Schuck, Edgar L., Luthman, Johan
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
13
Language:
english
Journal:
Alzheimer's & Dementia
DOI:
10.1016/j.jalz.2017.07.194
Date:
July, 2017
File:
PDF, 349 KB
english, 2017
Conversion to is in progress
Conversion to is failed